BENEV Announces Investigative Report on Combination Treatment with Human Adipose Tissue Stem Cell- derived Exosomes and Fractional CO2 Laser for Acne…
stemadminMesenchymal Stem CellsNo comments

This report outlines the investigative study that was conducted by a team of world renowned scientists, doctors including Hyuck Hoon KWON, Steven Hoseong YANG, Joon LEE, Byung Chul PARK, Kui Young PARK, Jae Yoon JUNG, Youin BAE,and Gyeong-Hun at Oaro Dermatology Institute (Seoul, South Korea), Guam Dermatology Institute (Guam, USA), Department of Dermatology, Dankook University, College of Medicine (Cheonan, South Korea), Department of Dermatology, Chung-Ang University, College of Medicine (Seoul, South Korea), and Department of Dermatology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine (Hwaseong, South Korea). Researchers involved in this study evaluated the clinical efficacy and safety of adipose tissue stem cell-derived exosomes as an adjuvant therapy after application of fractional CO2laser for acne scars. 25 patients consisting of 18 men and 7 women, between ages 19 and 54, 12 with Fitzpatrick Skin Type 3 and 13 with Fitzpatrick skin type 4 and atrophic acne scars, underwent the 12-week prospective, double-blind, randomized, split-face trial.

Read more
Unlocking The Unlimited Potential Of Stem Cells – CodeBlue
stemadminMesenchymal Stem CellsNo comments

As we enter 2021, it goes without saying that Covid-19 has changed how we live our lives. On top of pushing multiple industries to adopt digital processes like never before, the pandemic has accelerated the advancements in the field of biotechnology, with one of the most recent successes being the development of Covid-19 vaccines with a 95 per cent success rate. Prior to that, however, the world has already seen several leaps forward in the world of biotechnology over the past decades, especially in the field of medicine.

Read more
Global Placental Stem Cell Collection and Storage Market 2020 Segmented by Source, Application, and Geography Growth, Trends, and Forecast 2025 -…
stemadminMesenchymal Stem CellsNo comments

A recently published report titled Global Placental Stem Cell Collection and Storage Market 2020 by Company, Regions, Type and Application, Forecast to 2025 by MarketsandResearch.biz broadly analyzes the markets critical aspects such as the vendor landscape, market dynamics, and regional analysis.

Read more
American CryoStem Enters into a Cooperative Research and Development Agreement (CRADA) to Develop Standardized Treatment Protocols – BioSpace
stemadminMesenchymal Stem CellsNo comments

EATONTOWN, NJ / ACCESSWIRE / January 6, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a clinical stage biotechnology Company, global licensor and a pioneer in autologous cellular processing and therapies announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) authorized by published code 15 U.S.C. 3710a of US Title 15 Commerce and Trade. (https://www.disa.mil/about/cto/crada-process-overview) The Collaborative work will be conducted at the Biomedical Research Laboratory in Bethesda, Maryland

Read more
Mesenchymal Stem Cells Market Report Delivering Growth Analysis With Key Trends Of Top Companies (2020-2027) – LionLowdown
stemadminMesenchymal Stem CellsNo comments

The Global Mesenchymal Stem Cells Market analysis report published on IndustryGrowthInsights.com is a detailed study of market size, share and dynamics covered in XX pages and is an illustrative sample demonstrating market trends. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally

Read more
IMAC Stock Price Increases 23.97%: Why It Happened – Pulse 2.0
stemadminMesenchymal Stem CellsNo comments

The stock price of IMAC Holdings Inc (NASDAQ: IMAC) a company that provides orthopedic therapies through a chain of innovative medical advancements and care regeneration centers in the US has increased by 23.53% as it went from a previous close of $1.19 to $1.47. One of the biggest triggers for why the stock price increased is due to an announcement by the company that it completed a first infusion of stem cells in clinical study for the treatment of bradykinesia due to Parkinsons disease

Read more

Theme: Illdy.